Severe congenital neutropenia-developmental delay syndrome due to SRP54 deficiency Advocacy Hub | UniteRare

Regulatory Watchboard

1 event

Sep 1995

Leukine: FDA approved

Following induction chemotherapy in older adult patients with acute myelogenous leukemia to shorten time to neutrophil recovery and to reduce the incidence of severe and life-threatening infections and infections resulting in death.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Severe congenital neutropenia-developmental delay syndrome due to SRP54 deficiency.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Severe congenital neutropenia-developmental delay syndrome due to SRP54 deficiency.
Search all trials →

Search clinical trials for Severe congenital neutropenia-developmental delay syndrome due to SRP54 deficiency →